Discussion
deaths, drowsiness, nausea, vomiting
VIRUS, ADVERSE EVENTS, MINOR, INFLUENZA, EVENTS, INFLUENZA
The neuraminidase inhibitor oseltamivir selectively inhibits the activity of neuraminidase on the surface of respiratory tract viruses, preventing the reproduction and release of progeny virus particles in human cells and resulting in a therapeutic effect on influenza [Influenza viruses can share RNA segments that develop into new generations of strains and different subtypes [Arbidol has been approved in several countries for prophylaxis and treatment of influenza [In this study, we found that arbidol was safe and well-tolerated, and only a few minor events, such as nausea, vomiting, and drowsiness, were reported. No deaths were reported in either arm. This is similar to the reports of minor adverse events in other trials involving arbidol. It is noteworthy that arbidol has been used clinically for decades in other countries, with minimal side effects and a good pharmacokinetic profile [In addition to exerting antiviral and anti-inflammatory activities against various types of influenza viruses [